- Home
- Medical
- Clinical Medicine
- Amyloid and Amyloidosis
Amyloid and Amyloidosis
List Price:
$87.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Gilles Grateau, Robert A. Kyle, Martha Skinner
Format:
Paperback
Pages:
576
Publisher:
CRC Press (December 9, 2019)
Language:
English
ISBN-13:
9780367454258
Weight:
16oz
Dimensions:
7" x 10"
File:
TAYLORFRANCIS-TayFran_260415045548659-20260415.xml
Folder:
TAYLORFRANCIS
List Price:
$87.99
As low as:
$83.59
Publisher Identifier:
P-CRC
Discount Code:
H
Country of Origin:
United States
Pub Discount:
30
Audience:
Professional and scholarly
Imprint:
CRC Press
Case Pack:
1
Overview
This authoritative volume contains 179 chapters by international experts on recent developments in our understanding of amyloid proteins, protein folding disorders, and new and proposed clinical trials in amyloidosis. Topics include detection and characterization techniques; biological functions; genetics; disorders, diagnosis, and treatments, including organ transplants and drug therapies; results from extensive clinical studies; and epidemiology. This is a valuable resource for clinicians who care for patients with systemic and localized forms of amyloidosis, and for researchers in biochemistry, neurobiology, and cell biology.
